{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CBL/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:59:55.728Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9755,"canonical_name":"CBL & ASSOCIATES PROPERTIES INC","cik":"0000910612","uei":null,"lei":null,"duns":null,"ticker":"CBL"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":13},"count":13,"timeline":[{"ts":"2026-08-07","kind":"sec.filing","form_type":"10-Q","title":"10-Q — CBL & ASSOCIATES PROPERTIES INC — 2026-08-07","url_slug":"/sec/cik-0000910612/10-q/0001193125-26-339651","accession_number":"0001193125-26-339651","importance":45},{"ts":"2026-08-07","kind":"sec.filing","form_type":"8-K","title":"8-K — CBL & ASSOCIATES PROPERTIES INC — 2026-08-07","url_slug":"/sec/cik-0000910612/8-k/0001193125-26-339362","accession_number":"0001193125-26-339362","importance":35},{"ts":"2026-06-18","kind":"sec.form144","reporter":"Grody Howard B.","title":"Officer","shares":5728,"usd_value":275746,"security_title":"COMMON","approx_sale_date":"2026-06-18","accession_number":"0001193125-26-275112","importance":40.0551492},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"Grody Howard B.","title":"Exec VP-Leasing","shares":4728,"price_per_share":48.058,"usd_value":227218,"security_title":"Common Stock","importance":35.227218224},{"ts":"2026-06-18","kind":"sec.insider.s","reporter":"Grody Howard B.","title":"Exec VP-Leasing","shares":1000,"price_per_share":47.92,"usd_value":47920,"security_title":"Common Stock","importance":35.04792},{"ts":"2026-06-05","kind":"sec.form144","reporter":"Fields David Michael","title":"Director","shares":3592,"usd_value":170548,"security_title":"COMMON","approx_sale_date":"2026-06-05","accession_number":"0001193125-26-258499","importance":40.0341096},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"Fields David Michael","title":null,"shares":3592,"price_per_share":47.97,"usd_value":172308,"security_title":"Common Stock","importance":35.17230824},{"ts":"2026-06-02","kind":"sec.form144","reporter":"Jaenicke Benjamin W","title":"Officer","shares":6500,"usd_value":314340,"security_title":"COMMON","approx_sale_date":"2026-06-02","accession_number":"0001193125-26-252830","importance":40.062868},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Jaenicke Benjamin W","title":"EVP - Chief Financial Officer","shares":5974,"price_per_share":48.45,"usd_value":289440,"security_title":"Common Stock","importance":35.2894403},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Jaenicke Benjamin W","title":"EVP - Chief Financial Officer","shares":526,"price_per_share":48.565,"usd_value":25545,"security_title":"Common Stock","importance":35.02554519},{"ts":"2026-05-14","kind":"sec.form144","reporter":"Cobb Andrew Franklin","title":"Officer","shares":8150,"usd_value":379546,"security_title":"COMMON","approx_sale_date":"2026-05-14","accession_number":"0001193125-26-223001","importance":40.0759092},{"ts":"2026-05-14","kind":"sec.insider.s","reporter":"Cobb Andrew Franklin","title":"Exec VP-Accounting","shares":8099,"price_per_share":45.8046,"usd_value":370971,"security_title":"Common Stock","importance":35.3709714554},{"ts":"2026-05-14","kind":"sec.insider.s","reporter":"Cobb Andrew Franklin","title":"Exec VP-Accounting","shares":51,"price_per_share":46.31,"usd_value":2362,"security_title":"Common Stock","importance":35.00236181}]}